GL1X · GenesisL1 explorer

UniProt Q9BRQ3

Uridine diphosphate glucose pyrophosphatase NUDT22 (Q9BRQ3)

Uridine diphosphate glucose pyrophosphatase NUDT22 (UniProt Q9BRQ3), EC 3.6.1.45: 62 experimental structures and 1 predicted model on GenesisL1, 31 ligands bound, 66 pockets. Binding sites, druggability and experiment against…

UniProt
Q9BRQ3
Protein
Uridine diphosphate glucose pyrophosphatase NUDT22
EC
3.6.1.45
Experimental structures
62
Predicted models
1
Ligands
31
Pockets
66 · 30 records with a druggable one

Structures

63 records of Q9BRQ3 in the MolNFT archive: 62 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
5LF9Crystal structure of human NUDT22x-ray diffractionA—1 (best 0.69)
5LF9Crystal structure of human NUDT22x-ray diffractionA——
5LORhuman NUDT22x-ray diffractionA, BUPG5 (best 0.79)
5LORHuman NUDT22x-ray diffractionA, BUPG—
5LOUhuman NUDT22x-ray diffractionA, BPO44 (best 0.79)
5LOUHuman NUDT22x-ray diffractionA, BPO4—
5R50PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13371ax-ray diffractionARY42 (best 0.69)
5R50Pandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13371Ax-ray diffractionARY4—
5R51PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14003ax-ray diffractionARU42 (best 0.68)
5R51Pandda analysis group deposition -- crystal structure of human NUDT22 in complex with N14003Ax-ray diffractionARU4—
5R52PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14004ax-ray diffractionAGQJ2 (best 0.69)
5R52Pandda analysis group deposition -- crystal structure of human NUDT22 in complex with N14004Ax-ray diffractionAGQJ—
5R53PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13854ax-ray diffractionARYG2 (best 0.69)
5R53Pandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13854Ax-ray diffractionARYG—
5R54PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13582ax-ray diffractionARYM2 (best 0.68)
5R54Pandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13582Ax-ray diffractionARYM—
5R55PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13369ax-ray diffractionARYP2 (best 0.69)
5R55Pandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13369Ax-ray diffractionARYP—
5R56PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13688ax-ray diffractionAS072 (best 0.69)
5R56Pandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13688Ax-ray diffractionAS07—
5R57PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N08253bx-ray diffractionAS0P2 (best 0.67)
5R57Pandda analysis group deposition -- crystal structure of human NUDT22 in complex with N08253Bx-ray diffractionAS0P—
5R58PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13542ax-ray diffractionAS0S2 (best 0.68)
5R58Pandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13542Ax-ray diffractionAS0S—
5R59PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13441ax-ray diffractionA6SU2 (best 0.69)
5R59Pandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13441Ax-ray diffractionA6SU—
5R5APanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13663ax-ray diffractionAS0V2 (best 0.68)
5R5APandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13663Ax-ray diffractionAS0V—
5R5BPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13725ax-ray diffractionAS1G2 (best 0.68)
5R5BPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13725Ax-ray diffractionAS1G—
5R5CPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13956ax-ray diffractionAGQP2 (best 0.69)
5R5CPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13956Ax-ray diffractionAGQP—
5R5DPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13564ax-ray diffractionAS1J2 (best 0.68)
5R5DPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13564Ax-ray diffractionAS1J—
5R5EPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13848ax-ray diffractionAGV12 (best 0.68)
5R5EPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13848Ax-ray diffractionAGV1—
5R5FPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13793ax-ray diffractionAN082 (best 0.69)
5R5FPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13793Ax-ray diffractionAN08—
5R5GPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13707ax-ray diffractionAS1M2 (best 0.69)
5R5GPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13707Ax-ray diffractionAS1M—
5R5HPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13706Ax-ray diffractionAJOV—
5R5IPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N06325bx-ray diffractionAS1V2 (best 0.67)
5R5IPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N06325Bx-ray diffractionAS1V—
5R5JPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13964ax-ray diffractionAMH53 (best 0.69)
5R5JPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13964Ax-ray diffractionAMH5—
5R5KPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13960ax-ray diffractionAS2J2 (best 0.69)
5R5KPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13960Ax-ray diffractionAS2J—
5R5LPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13589ax-ray diffractionAS2S2 (best 0.68)
5R5LPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13589Ax-ray diffractionAS2S—
5R5MPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N14123Ax-ray diffractionAS2V—
5R5NPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13595ax-ray diffractionAJHP2 (best 0.68)
5R5NPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13595Ax-ray diffractionAJHP—
5R5OPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14027ax-ray diffractionAV3J2 (best 0.68)
5R5OPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N14027Ax-ray diffractionAV3J—
5R5PPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13910ax-ray diffractionAS2Y2 (best 0.68)
5R5PPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13910Ax-ray diffractionAS2Y—
5R5QPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13920Ax-ray diffractionA7MU—
5R5RPanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14078ax-ray diffractionAS342 (best 0.69)
5R5RPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N14078Ax-ray diffractionAS34—
5R5SPandda analysis group deposition -- crystal structure of human NUDT22 in complex with N13775Ax-ray diffractionANU4—

3 records more on the page itself.

Ligands

  • 6SU · methyl 3-(methylsulfonylamino)benzoate · in 2 records
  • GQJ · methyl (2~{S},4~{R})-1-(furan-2-ylcarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylate · in 2 records
  • GQP · 1-[(4-fluorophenyl)methyl]benzimidazole · in 2 records
  • GV1 · ~{N},~{N},5,6-tetramethylthieno[2,3-d]pyrimidin-4-amine · in 2 records
  • JHP · 4-chloro-N-cyclopentyl-1-methyl-1H-pyrazole-3-carboxamide · in 2 records
  • MH5 · 3-[(5-methylthiophen-2-yl)methylamino]benzoic acid · in 2 records
  • N08 · ~{N}-[2-(4-fluorophenyl)ethyl]furan-2-carboxamide · in 2 records
  • PO4 · Phosphate ion · in 2 records
  • RU4 · 4-(1,2,3-thiadiazol-4-yl)phenyl ethylcarbamate · in 2 records
  • RY4 · N-[4-(aminomethyl)phenyl]methanesulfonamide · in 2 records
  • RYG · ~{N}-[(3~{R})-2-oxidanylideneazepan-3-yl]furan-2-carboxamide · in 2 records
  • RYM · 4-(benzimidazol-1-ylmethyl)benzenecarbonitrile · in 2 records
  • RYP · ~{N}-methyl-1-pyridin-4-yl-methanamine · in 2 records
  • S07 · 2-(2,4-dimethylphenoxy)-1-morpholin-4-yl-ethanone · in 2 records
  • S0P · ~{N}-(4-cyanophenyl)ethanamide · in 2 records
  • S0S · (3~{R},4~{R})-1,1-bis(oxidanylidene)-4-(pyridin-3-ylmethylamino)thiolan-3-ol · in 2 records
  • S0V · morpholin-4-yl(1,2,3-thiadiazol-4-yl)methanone · in 2 records
  • S1G · 4-[(phenylmethyl)amino]benzoic acid · in 2 records
  • S1J · 3-azanyl-4-(pyridin-3-ylmethylamino)benzoic acid · in 2 records
  • S1M · methyl 2-[(2~{S})-1-ethanoyl-3-oxidanylidene-piperazin-2-yl]ethanoate · in 2 records
  • S1V · 1-ethanoylpiperidine-4-carbonitrile · in 2 records
  • S2J · methyl 2-[(2~{R})-1-(ethylcarbamoyl)-3-oxidanylidene-piperazin-2-yl]ethanoate · in 2 records
  • S2S · 4-(methylsulfonylamino)benzamide · in 2 records
  • S2Y · ~{N}-[(4-fluorophenyl)methyl]-4-methoxy-aniline · in 2 records
  • S34 · 2-cyano-~{N}-(pyridin-4-ylmethyl)ethanamide · in 2 records
  • UPG · Uridine-5'-diphosphate-glucose · in 2 records
  • V3J · (4,7-dihydro-2H-1lambda~4~,2,3-benzothiadiazol-5-yl) (morpholin-4-yl)methanone · in 2 records
  • 7MU · 4-chloranyl-~{N}-methyl-pyridine-2-carboxamide · in 1 record
  • JOV · 3-chloro-N-(1-hydroxy-2-methylpropan-2-yl)benzamide · in 1 record
  • NU4 · 2-methyl-N-(pyridin-4-yl)furan-3-carboxamide · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.